908 Devices Inc. (MASS): Price and Financial Metrics


908 Devices Inc. (MASS): $21.44

0.85 (+4.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MASS POWR Grades


  • Growth is the dimension where MASS ranks best; there it ranks ahead of 61.12% of US stocks.
  • The strongest trend for MASS is in Momentum, which has been heading down over the past 179 days.
  • MASS's current lowest rank is in the Stability metric (where it is better than 11.62% of US stocks).

MASS Stock Summary

  • MASS's went public 1.28 years ago, making it older than merely 1.42% of listed US stocks we're tracking.
  • With a price/sales ratio of 15.3, 908 Devices Inc has a higher such ratio than 90.72% of stocks in our set.
  • The volatility of 908 Devices Inc's share price is greater than that of 85.26% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to 908 Devices Inc, a group of peers worth examining would be TACT, AMSWA, OSUR, INTZ, and AVGR.
  • Visit MASS's SEC page to see the company's official filings. To visit the company's web site, go to www.908devices.com.

MASS Valuation Summary

  • In comparison to the median Healthcare stock, MASS's price/earnings ratio is 311.23% lower, now standing at -77.1.
  • Over the past 37 weeks, MASS's price/earnings ratio has gone up 17.2.
  • MASS's EV/EBIT ratio has moved up 33.7 over the prior 37 weeks.

Below are key valuation metrics over time for MASS.

Stock Date P/S P/B P/E EV/EBIT
MASS 2021-08-31 37.0 7.9 -77.1 -73.9
MASS 2021-08-30 37.9 8.0 -78.9 -75.9
MASS 2021-08-27 36.2 7.7 -75.4 -72.1
MASS 2021-08-26 34.0 7.2 -70.8 -67.0
MASS 2021-08-25 34.7 7.4 -72.4 -68.8
MASS 2021-08-24 35.8 7.6 -74.6 -71.2

MASS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MASS has a Quality Grade of C, ranking ahead of 42% of graded US stocks.
  • MASS's asset turnover comes in at 0.188 -- ranking 66th of 75 Measuring and Control Equipment stocks.
  • 500 - Internal server error

The table below shows MASS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.188 0.52 -0.825

MASS Price Target

For more insight on analysts targets of MASS, see our MASS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $55.00 Average Broker Recommendation 1.12 (Strong Buy)

MASS Stock Price Chart Interactive Chart >

Price chart for MASS

MASS Price/Volume Stats

Current price $21.44 52-week high $39.81
Prev. close $20.59 52-week low $12.60
Day low $20.12 Volume 283,295
Day high $21.60 Avg. volume 314,278
50-day MA $16.19 Dividend yield N/A
200-day MA $21.99 Market Cap 673.37M

908 Devices Inc. (MASS) Company Bio


908 Devices, Inc. develops measurement devices for chemical and biochemical analysis. It develops its products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.


MASS Latest News Stream


Event/Time News Detail
Loading, please wait...

MASS Latest Social Stream


Loading social stream, please wait...

View Full MASS Social Stream

Latest MASS News From Around the Web

Below are the latest news stories about 908 Devices Inc that investors may wish to consider to help them evaluate MASS as an investment opportunity.

908 Devices to Report Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, March 7, 2022. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of

Business Wire | February 15, 2022

908 Devices (NASDAQ:MASS) shareholders have endured a 80% loss from investing in the stock a year ago

As every investor would know, you don't hit a homerun every time you swing. But it would be foolish to simply accept...

Yahoo | February 14, 2022

908 Devices to Participate in Upcoming Investor Conferences

BOSTON, February 08, 2022--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following virtual investor conferences.

Yahoo | February 8, 2022

15 Worst Stock Picks of Cathie Wood

In this article, we discuss the 15 worst stock picks of Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to the 5 Worst Stock Picks of Cathie Wood. Cathie Wood, the chief ARK Investment Management, is often hailed as the champion of “disruptive innovation” at the stock market. […]

Yahoo | January 21, 2022

908 Devices Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021

BOSTON, January 10, 2022--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced preliminary, unaudited revenue for the fourth quarter and full year ended December 31, 2021.

Yahoo | January 10, 2022

Read More 'MASS' Stories Here

MASS Price Returns

1-mo 59.17%
3-mo 4.03%
6-mo -17.12%
1-year -42.23%
3-year N/A
5-year N/A
YTD -17.12%
2021 -54.57%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4816 seconds.